Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Tango Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- −7 vs. Q1 2025
- Shares held
- 127.2M
- +20.0M (+18.6%) vs. Q1 2025
- Total value
- $651.7M
- +$504.7M (+343.4%) vs. Q1 2025
- New holders
- 21
- 42 more added
- Sold out
- 28
- 30 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 247 | $6.60B |
| Q1 2026 | 194 | $3.78B |
| Q4 2025 | 170 | $1.53B |
| Q3 2025 | 141 | $1.18B |
| Q2 2025 | 115 | $651.7M |
| Q1 2025 | 122 | $147.0M |
| Q4 2024 | 138 | $329.2M |
| Q3 2024 | 121 | $781.2M |
| Q2 2024 | 120 | $846.0M |
| Q1 2024 | 126 | $781.2M |
| Q4 2023 | 121 | $927.1M |
| Q3 2023 | 100 | $999.9M |
| Q2 2023 | 89 | $226.8M |
| Q1 2023 | 92 | $275.9M |
| Q4 2022 | 82 | $498.4M |
| Q3 2022 | 87 | $246.8M |
| Q2 2022 | 77 | $319.1M |
| Q1 2022 | 72 | $528.2M |
| Q4 2021 | 58 | $741.0M |
| Q3 2021 | 46 | $844.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 3,169,226 | $16.2M | 0.01% | −143,223−4.3% | Reduced |
| Balyasny Asset Management LLC | 3,247,463 | $16.6M | 0.04% | +27,892+0.9% | Added |
| Siren, L.L.C. | 3,364,814 | $17.2M | 0.89% | +799,472+31.2% | Added |
| Nantahala Capital Management, LLC | 3,439,594 | $17.6M | 1.25% | +451,611+15.1% | Added |
| Vanguard Group Inc | 4,026,800 | $20.6M | 0.00% | +151,255+3.9% | Added |
| Gilead Sciences, Inc. | 4,854,443 | $24.9M | 1.94% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,463,266 | $28.0M | 0.00% | +1,431,254+35.5% | Added |
| Nextech Invest, Ltd. | 5,533,980 | $28.3M | 5.36% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 5,905,349 | $30.2M | 0.05% | +5,905,349 | New |
| Woodline Partners LP | 6,029,906 | $30.9M | 0.16% | +5,523,718+1,091.2% | Added |
| Farallon Capital Management, L.L.C. | 9,157,000 | $46.9M | 0.21% | +4,546,070+98.6% | Added |
| Boxer Capital Management, LLC | 9,771,485 | $50.0M | 25.18% | −609,514−5.9% | Reduced |
| EcoR1 Capital, LLC | 10,630,736 | $54.4M | 3.23% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 10,736,000 | $55.0M | 6.28% | 00.0% | Unchanged |
| TRV GP IV, LLC | 16,859,075 | $86.3M | 52.85% | 00.0% | Unchanged |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −655,158−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −352,897−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −241,729−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −211,797−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −116,498−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −97,000−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −82,657−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −68,269−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −65,560−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −65,327−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −65,146−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −57,086−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −41,346−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −34,060−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −30,303−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −25,801−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −23,373−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −17,029−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −10,586−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −6,566−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −1,572−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −1,198−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −969−100.0% | Sold out |
| UMA Financial Services, Inc. | 0 | $0 | 0.00% | −568−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −321−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |